Ploenchan Chetchotisakd

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha et al. · The Lancet · 2007 · 689 citations

Invasive Candidosis, Antifungal Agent, Antifungal Agents +8

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 676 citations

Single-arm Open-label Trial, Antifungal Agent, Antifungal Agents +4

Adult-Onset Immunodeficiency in Thailand and Taiwan

Sarah Browne, Peter D. Burbelo, Ploenchan Chetchotisakd et al. · New England Journal of Medicine · 2012 · 526 citations · Full text

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría et al. · The Lancet · 2008 · 482 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +9

Increasing Incidence of Human Melioidosis in Northeast Thailand

Direk Limmathurotsakul, Surasakdi Wongratanacheewin, Nittaya Teerawattanasook et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 424 citations · Full text